HB 4 — Tianeptine; include in Schedule I controlled substance list.

2-(ethylamino)-2-(2-thienyl)-cyclohexanone;

other names for zolazepam include:

4-(2-fluorophenyl)-6,8-dihydro 1,3, 8-trimethylpyrazolo-[3,4-e](1,4)-diazepin-7(1H)-one, flupyrazapon.

(c) Nalorphine.

(d) Any material, compound, mixture or preparation which contains any quantity of ephedrine or pseudoephedrine, except for any product that contains any quantity of H.

4 *HR31/R944**HR31/R944SG* ~ OFFICIAL ~ 23/HR31/R94423/HR31/R944SG PAGE 3(MCL\JAB) (28)pseudoephedrine Diampromide;or ephedrine that is sold subject to the quantity restrictions authorized in Section 73-21-124.

(29)(e) Diethylthiambutene;Narcotic drugs.

(30)Any Difenoxin;material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:

(31)(1) Dimenoxadol;Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;

(32)(2) Dimepheptanol;Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;

(33)(3) Dimethylthiambutene;Not more than one and eight-tenths (1.8) grams of dihydrocodeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;

(34)(4) DioxaphetylNot butyrate;more than three hundred (300) milligrams of ethylmorphine, or any of its salts, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;

(35) Dipipanone;

(36) Ethylmethylthiambutene;

(37) Etonitazene;

(38) Etoxeridine;

(39) Fentanyl carbamate (ethyl(1-phenethylpiperidin-4-yl)(phenyl)carbamate);

(40) Fentanyl-related substances, meaning any substance not otherwise listed under another schedule and for which no exemption or approval is in effect under Section 505 of the Federal Food, Drug, and Cosmetic Act [21 USC 355] that is structurally related to fentanyl by one or more of the following modifications:

(A) Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

(B) Substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups;

4 *HR31/R944**HR31/R944SG* ~ OFFICIAL ~ 23/HR31/R94423/HR31/R944SG PAGE 4(MCL\JAB) (C)(5) SubstitutionNot inmore than five hundred (500) milligrams of opium per one hundred (100) milliliters or onper theone piperidinehundred ring(100) withgrams, alkyl,or alkenyl,not alkoxyl,more ester,than ether,twenty-five hydroxyl,(25) halo,milligrams haloalkyl,per aminodosage unit, with one or nitromore groups;active, nonnarcotic ingredients in recognized therapeutic amounts;

(D)(6) ReplacementNot ofmore thethan anilinefifty ring(50) withmilligrams of morphine, or any aromaticof monocycleits whethersalts, per one hundred (100) milliliters or notper furtherone substitutedhundred in(100) grams with one or onmore theactive, aromaticnonnarcotic monocycle;ingredients in recognized therapeutic amounts.

and/or(f) (E)Anabolic Replacementsteroids. of the N-propionyl group by another acyl group.

(41)Unless 4-Fluoroisobutyrylspecifically fentanylexempted (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide),or alsolisted knownin asanother para-fluoroisobutyrylschedule, fentanyl);any material, compound, mixture or preparation containing any quantity of any of the following anabolic steroids (any drug or hormonal substance chemically and pharmacologically related to testosterone other than estrogens, progestins, corticosteroids and dehydroepiandrosterone):

(42)(1) 2'-Fluoro3beta,17-dihydroxy-5a-androstane; ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl) propionamide), also known as 2'-fluoro 2-fluorofentanyl;

(43)(2) Furanyl3alpha,17beta-dihydroxy-5a-androstane; fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide);

(44)(3) Furethidine;5alpha-androstan-3,17-dione;

(45)(4) Hydroxypethidine;1-androstenediol (3beta,17beta-dihydroxy-5alpha-androst-1-ene);

(46)(5) Isobutyryl1-androstenediol fentanyl(3alpha,17beta-dihydroxy-5alpha-androst-1-ene); (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide);

(47)(6) Isotonitazene4-androstenediol (N,N-diethyl-2-(2-(4(3beta,17beta-dihydroxy-androst-4-ene); isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine);

(48) Ketobemidone (including the optical and geometric isomers);

(49) Levomoramide;

4 *HR31/R944**HR31/R944SG* ~ OFFICIAL ~ 23/HR31/R94423/HR31/R944SG PAGE 5(MCL\JAB) (50)(7) Levophenacylmorphan;5-androstenediol (3beta,17beta-dihydroxy-androst-5-ene);

(51)(8) Methoxyacetyl1-androstenedione fentanyl([5alpha]-androst-1-en-3, (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);17-dione);

(52)(9) 4'-Methyl4-androstenedione acetyl(androst-4-en-3,17-dione); fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide);

(53)(10) 3-Methylfentanyl5-androstenedione (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);(androst-5-en-3,17-dione);

(54)(11) 3-MethylthiofentanylBolasterone (N-[3-methyl-1-(7alpha,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one); (2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide);

(55)(12) Morpheridine;Boldenone (17beta-hydroxyandrost-1,4,-diene-3-one);

(56)(13) MPPPBoldione (1-methyl-4-phenyl-4-propionoxypiperidine);(androsta-1,4-diene-3,17-dione);

(57)(14) MT-45Calusterone (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine);(7beta,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one);

(58)(15) Noracymethadol;Clostebol (4-chloro-17beta-hydroxyandrost-4-en-3-one);

(59)(16) Norlevorphanol;Dehydrochloromethyltestosterone (4-chloro-17beta-hydroxy-17alpha-methylandrost-1,4-dien-3-one);

(60)(17) Normethadone;Desoxymethyltestosterone (17alpha-methyl-5alpha-androst-2-en-17beta-ol, also known as madol);

(61)(18) Norpipanone;Delta1-dihydrotestosterone (also known as 1-testosterone) (17beta-hydroxy-5alpha-androst-1-en-3-one);

(62)(19) Ocfentanil4-dihydrotestosterone (N-(2-fluorophenyl)-2-methoxy-N-(17beta-hydroxy-androstan-3-one); (1-phenethylpiperidin-4-yl)acetamide);

(63) Ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide);

(64) Ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide), also known as 2-fluorobutyryl fentanyl;

4 *HR31/R944**HR31/R944SG* ~ OFFICIAL ~ 23/HR31/R94423/HR31/R944SG PAGE 6(MCL\JAB) (65)(20) Ortho-FluorofentanylDrostanolone (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide),(17beta-hydroxy-2alpha-methyl-5alpha-androstan-3-one); also known as 2-fluorofentanyl;

(66)(21) Ortho-FluoroisobutyrylEthylestrenol fentanyl(17alpha-ethyl-17beta-hydroxyestr-4-ene); (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

(67)(22) Ortho-MethylFluoxymesterone acetylfentanyl(9-fluoro-17alpha-methyl-11beta, (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide),17beta-dihydroxyandrost-4-en-3-one); also known as 2-methyl acetylfentanyl;

(68)(23) Ortho-MethylFormebolone methoxyacetyl(2-formyl-17alpha-methyl-11alpha,17beta-dihydroxyandrost-1, fentanyl4-dien-3-one); (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl) acetamide), also known as 2-methyl methoxyacetyl fentanyl;

(69)(24) Para-ChloroisobutyrylFurazabol fentanyl(17alpha-methyl-17beta-hydroxyandrostano[2,3-c]-furazan); (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

(70)(25) Para-Fluorobutyryl13beta-ethyl-17alpha-hydroxygon-4-en-3-one; fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);

(71)(26) Para-Fluorofentanyl4-hydroxytestosterone (N-(4-fluorophenyl)(4,17beta-dihydroxyandrost-4-en-3-one); -N-[1-(2-phenylethyl)-4-piperidinyl]propanamide);

(72)(27) Para-Fluoro4-hydroxy-19-nortestosterone furanyl(4,17beta-dihydroxy-estr-4-en-3-one); fentanyl N-(4-fluorophenyl)-N- (1-phenethylpiperidin-4-yl)furan-2-carboxamide);

(73)(28) Para-MethoxybutyrylMestanolone fentanyl(17alpha-methyl-17beta-hydroxy-5-androstan-3-one); (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);

(74)(29) Para-MethylfentanylMesterolone (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide),(1alpha-methyl-17beta-hydroxy-[5alpha]-androstan-3-one); also known as 4-methylfentanyl);

(30) Methandienone (17alpha-methyl-17beta-hydroxyandrost-1,4-dien-3-one);

(31) Methandriol (17alpha-methyl-3beta, 17beta-dihydroxyandrost-5-ene);

4 *HR31/R944**HR31/R944SG* ~ OFFICIAL ~ 23/HR31/R94423/HR31/R944SG PAGE 7(MCL\JAB) (75)(32) PEPAPMethasterone (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);(2[alpha], 17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one;

(76)(33) Phenadoxone;Methenolone (1-methyl-17beta-hydroxy-5alpha-androst-1-en-3-one);

(77)(34) Phenampromide;17alpha-methyl-3beta, 17beta-dihydroxy-5a-androstane;

(78)(35) Phenomorphan;17alpha-methyl-3alpha, 17beta-dihydroxy-5a-androstane;

(79)(36) Phenoperidine;17alpha-methyl-3beta, 17beta-dihydroxyandrost-4-ene;

(80)(37) Phenyl17alpha-methyl-4-hydroxynandrolone fentanyl(17alpha-methyl-4-hydroxy-17beta-hydroxyestr-4-en-3-one); (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide), also known as benzoyl fentanyl;

(81)(38) Piritramide;Methyldienolone (17alpha-methyl-17beta-hydroxyestra-4,9(10)-dien-3-one);

(82)(39) Proheptazine;Methyltrienolone (17alpha-methyl-17beta-hydroxyestra-4,9-11-trien-3-one);

(83)(40) Properidine;Methyltestosterone (17alpha-methyl-17beta-hydroxyandrost-4-en-3-one);

(84)(41) Propiram;Mibolerone (7alpha,17alpha-dimethyl-17beta-hydroxyestr-4-en-3-one);

(85)(42) Racemoramide;17alpha-methyl-Delta1-dihydrotestosterone (17b beta-hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one) (also known as 17-alpha-methyl-1-testosterone);

(86)(43) TetrahydrofuranylNandrolone fentanyl(17beta-hydroxyestr-4-en-3-one); (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2- carboxamide);

(87) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);

(88) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide), also known as 2-thiofuranyl fentanyl or thiophene fentanyl;

(89) Tilidine;

(90) Trimeperidine;

(91) U-47700, (3,4-dichloro-N- H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 8(MCL\JAB) [2-(dimethylamino)cyclohexyl]-N-methylbenzamide);

(92) Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide).

(93) Tianeptine and any salt, sulfate, free acid, or other preparation of Tianeptine, and any salt, sulfate, free acid, compound, derivative, precursor, or preparation thereof which is substantially chemically equivalent or identical with Tianeptine.

(c) Opium derivatives.

Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1) Acetorphine;

(2) Acetyldihydrocodeine;

(3) Benzylmorphine;

(4) Codeine methylbromide;

(5) Codeine-N-Oxide;

(6) Cyprenorphine;

(7) Desomorphine;

(8) Dihydromorphine;

(9) Drotebanol;

(10) Etorphine (except hydrochloride salt);

(11) Heroin;

(12) Hydromorphinol;

(13) Methyldesorphine;

4 *HR31/R944**HR31/R944SG* ~ OFFICIAL ~ 23/HR31/R94423/HR31/R944SG PAGE 9(MCL\JAB)8(MCL\JAB) (14)(44) Methyldihydromorphine;19-nor-4-androstenediol (3beta,17beta-dihydroxyestr-4-ene);

(15)(45) Monoacetylmorphine;19-nor-4-androstenediol (3a,17beta-dihydroxyestr-4-ene);

(16)(46) Morphine19-nor-5-androstenediol methylbromide;(3beta,17beta-dihydroxyestr-5-ene);

(17)(47) Morphine19-nor-5-androstenediol methylsulfonate;(3alpha,17beta-dihydroxyestr-5-ene);

(18)(48) Morphine-N-Oxide;19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene3,17-dione, 19-norandrosta-4,9(10)-diene-3,17-dione);

(19)(49) Myrophine;19-nor-4-androstenedione (estr-4-en-3,17-dione);

(20)(50) Nicocodeine;19-nor-5-androstenedione (estr-5-en-3,17-dione);

(21)(51) Nicomorphine;Norbolethone (13beta,17alpha-diethyl-17beta-hydroxygon-4-en-3-one);

(22)(52) Normorphine;Norclostebol (4-chloro-17beta-hydroxyestr-4-en-3-one);

(23)(53) Pholcodine;Norethandrolone (17alpha-ethyl-17beta-hydroxyestr-4-en-3-one);

(24)(54) Thebacon.Normethandrolone (17alpha-methyl-17beta-hydroxyestr-4-en-3-one);

(d)(55) HallucinogenicOxandrolone substances.(17alpha-methyl-17beta-hydroxy-2-oxa-[5alpha]-androstan-3-one);

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric) and salts of isomers, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1) Alpha-ethyltryptamine;

(2) 4-bromo-2,5-dimethoxy-amphetamine;

(3) 4-bromo-2,5-dimethoxyphenethylamine;

(4) 2,5-dimethoxyamphetamine;

(5) 2,5-dimethoxy-4-ethylamphetamine (DOET);

(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7);

4 *HR31/R944**HR31/R944SG* ~ OFFICIAL ~ 23/HR31/R94423/HR31/R944SG PAGE 10(MCL\JAB)9(MCL\JAB) (7)(56) 4-methoxyamphetamine;Oxymesterone (17alpha-methyl-4,17beta-dihydroxyandrost-4-en-3-one);

(8)(57) 5-methoxy-3,4-methylenedioxy-amphetamine;Oxymetholone (17alpha-methyl-2-hydroxymethylene-17beta-hydroxy-[5alpha]- androstan-3-one);

(9)(58) 4-methyl-2,5-dimethoxy-amphetamine;Prostanozol (17[beta]-hydroxy-5[alpha]-androstano[3,2-c]pyrazole) (59) Stanozolol (17alpha-methyl-17beta-hydroxy-[5alpha]-androst-2-eno[3,2-c]- pyrazole);

(10)(60) 3,4-methylenedioxyStenbolone amphetamine;(17beta-hydroxy-2-methyl-[5alpha]-androst-1-en-3-one);

(11)(61) 3,4-methylenedioxymethamphetamineTestolactone (MDMA);(13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);

(12)(62) 3,4-methylenedioxy-N-ethylamphetamineTestosterone (also(17beta-hydroxyandrost-4-en-3-one); known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA);

(13)(63) N-hydroxy-3,4-methylenedioxyamphetamineTetrahydrogestrinone (also(13beta,17alpha-diethyl-17beta-hydroxygon-4,9,11-trien-3-one); known as N-hydroxy MDA, N-OHMDA, and N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine);

(14)(64) 3,4,5-trimethoxyTrenbolone amphetamine;(17beta-hydroxyestr-4,9,11-trien-3-one);

(15)(65) 5-methoxy-N,N-dimethyltryptamineAny (5-MeO-DMT);salt, ester, or ether of a drug or substance described in this paragraph.

(16)Except Alpha-methyltryptaminesuch (alsoterm knowndoes asnot AMT);include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman H.

(17) Bufotenine;

(18) Diethyltryptamine;

(19) Dimethyltryptamine;

(20) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT);

(21) Ibogaine;

(22) Lysergic acid diethylamide (LSD);

(23) (A) Marijuana (Hemp as defined and regulated under Sections 69-25-201 through 69-25-221 and Cannabidiol contained in a legend drug product approved by the Federal Food and Drug Administration or obtained under Section 41-29-136 are exempt under Schedule I);

H.

4 *HR31/R944**HR31/R944SG* ~ OFFICIAL ~ 23/HR31/R94423/HR31/R944SG PAGE 11(MCL\JAB)10(MCL\JAB) (B)species Hashish;and that has been approved by the Secretary of Health and Human Services for such administration.

(24)If Mescaline;any person prescribes, dispenses, or distributes such steroid for human use, the person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this paragraph.

(25)(g) Parahexyl;Any material, compound, mixture or preparation which contains any quantity of buprenorphine or its salts.

(26)(h) Peyote;Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product.

(27)(i) N-ethyl-3-piperidylAny benzilate;material, compound, mixture, or preparation which contains any quantity of Tianeptine (7-((3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]th iazepin-11-yl)amino)heptanoic acid) or its salts, isomers, salts of isomers, sulfate, free acid or derivative thereof.

(28)(B) N-methyl-3-piperidylAny benzilate;material, compound, mixture or preparation which contains any quantity of a Schedule III controlled substance other than butalbital, and is listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law.

(29) Psilocybin;

(30) Psilocyn;

(31) Tetrahydrocannabinols, meaning tetrahydrocannabinols contained in a plant of the genus Cannabis (cannabis plant), as well as the synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant such as the following:

(A) 1 cis or trans tetrahydrocannabinol;

(B) 6 cis or trans tetrahydrocannabinol;

(C) 3,4 cis or trans tetrahydrocannabinol.

(Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of atomic positions, are covered.) ("Tetrahydrocannabinols" excludes dronabinol and nabilone.) For purposes of this paragraph, tetrahydrocannabinols do not H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 12(MCL\JAB) include hemp or hemp products regulated under Sections 69-25-201 through 69-25-221.

However, the following products are exempted from control:

(i) THC-containing industrial products made from cannabis stalks (e.g., paper, rope and clothing);

(ii) Processed cannabis plant materials used for industrial purposes, such as fiber retted from cannabis stalks for use in manufacturing textiles or rope;

(iii) Animal feed mixtures that contain sterilized cannabis seeds and other ingredients (not derived from the cannabis plant) in a formula designed, marketed and distributed for nonhuman consumption;

(iv) Personal care products that contain oil from sterilized cannabis seeds, such as shampoos, soaps, and body lotions (if the products do not cause THC to enter the human body);

(v) Hemp as regulated under Sections 69-25-201 through 69-25-221;

and (vi) Any product derived from the hemp plant designed for human ingestion and/or consumption that is approved by the United States Food and Drug Administration;

(32) Phencyclidine;

(33) Ethylamine analog of phencyclidine (PCE);

(34) Pyrrolidine analog of phencyclidine (PHP, PCPy);

(35) Thiophene analog of phencyclidine;

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 13(MCL\JAB) (36) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine (TCPy);

(37) 4-methylmethcathinone (mephedrone);

(38) 3,4-methylenedioxypyrovalerone (MDPV);

(39) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine (2C-E);

(40) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine (2C-D);

(41) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);

(42) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);

or 2,5-dimethoxy-4-iodophenethylamine;

(43) 2-[4-(ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2);

(44) 2-[4-(isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4);

(45) 2-(2,5-dimethoxyphenyl)ethanamine (2C-H);

(46) 2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine (2C-N);

(47) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);

(48) 3,4-methylenedioxy-N-methylcathinone(methylone);

(49) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe;

2C-B-NBOMe;

25B;

Cimbi-36);

(50) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe;

2C-C-NBOMe;

25C;

Cimbi-82);

(51) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine or H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 14(MCL\JAB) N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe;

2C-I-NBOMe;

25I;

Cimbi-5);

(52) 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1, 4-benzodiazepin-2-one (also known as Phenazepam);

(53) 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8, 11,12-tetraazatricyclo[8.3.0.0]trideca-2(6),4,7,10,12-pentaene (also known as Etizolam);

(54) Salvia divinorum;

(55) Synthetic cannabinoids.

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of a synthetic cannabinoid found in any of the following chemical groups, whether or not substituted to any extent, or any of those groups which contain any synthetic cannabinoid salts, isomers, or salts of isomers, whenever the existence of such salts, isomers, or salts of isomers is possible within the specific chemical designation, including all synthetic cannabinoid chemical analogues in such groups:

(A) (6aR,10aR)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol (also known as HU-210 or 1,1-dimethylheptyl-11-hydroxy-delta8-tetrahydrocannabinol);

(B) Naphthoylindoles and naphthylmethylindoles, being any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane, whether or not substituted H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 15(MCL\JAB) in the indole ring to any extent, or in the naphthyl ring to any extent;

(C) Naphthoylpyrroles, being any compound structurally derived from 3-(1-naphthoyl)pyrrole, whether or not substituted in the pyrrole ring to any extent, or in the naphthyl ring to any extent;

(D) Naphthylmethylindenes, being any compound structurally derived from 1-(1-naphthylmethyl)indene, whether or not substituted in the indene ring to any extent or in the naphthyl ring to any extent;

(E) Phenylacetylindoles, being any compound structurally derived from 3-phenylacetylindole, whether or not substituted in the indole ring to any extent or in the phenyl ring to any extent;

(F) Cyclohexylphenols, being any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol, whether or not substituted in the cyclohexyl ring to any extent or in the phenolic ring to any extent;

(G) Benzoylindoles, whether or not substituted in the indole ring to any extent or in the phenyl ring to any extent;

(H) Adamantoylindoles, whether or not substituted in the indole ring to any extent or in the adamantoyl ring system to any extent;

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 16(MCL\JAB) (I) Tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives, except where contained in cannabis or cannabis resin;

(J) 3-Cyclopropylmethanone indole or 3-Cyclobutylmethanone indole or 3-Cyclopentylmethanone indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the cyclopropyl, cyclobutyl or cyclopentyl rings to any extent;

(K) Quinolinyl ester indoles, being any compound structurally derived from 1H-indole-3carboxylic acid-8-quinolinyl ester, whether or not substituted in the indole ring to any extent or the quinolone ring to any extent;

(L) 3-carboxamide-1H-indazoles, whether or not substituted in the indazole ring to any extent and substituted to any degree on the carboxamide nitrogen and 3-carboxamide-1H-indoles, whether or not substituted in the indole ring to any extent and substituted to any degree on the carboxamide nitrogen;

(M) Cycloalkanemethanone Indoles, whether or not substituted at the nitrogen atom on the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the cycloalkane ring to any extent;

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 17(MCL\JAB) (56) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, also known as NM2201 or CBL2201;

(57) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H- pyrrolo[2,3-b]pyridine-3-carboxamide, also known as 5F-CUMYL-P7AICA;

(58) 1-(4-methoxyphenyl)-N-methylpropan-2-amine, also known as para-methoxymethamphetamine or PMMA.

(e) Depressants.

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Clonazolam, 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine;

(2) Flualprazolam, 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4 ]benzodiazepine;

(3) Flubromazepam, 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one;

(4) Flubromazolam, H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 18(MCL\JAB) 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepin;

(5) Gamma-hydroxybutyric acid (other names include:

GHB, gamma-hydroxybutyrate;

4-hydroxybutyrate;

4-hydroxybutanoic acid;

sodium oxybate;

sodium oxybutyrate);

(6) Mecloqualone;

(7) Methaqualone.

(f) Stimulants.

Any material, compound, mixture or preparation which contains any quantity of the following central nervous system stimulants including optical salts, isomers and salts of isomers unless specifically excepted or unless listed in another schedule:

(1) Aminorex;

(2) N-benzylpiperazine (also known as BZP and 1-benzylpiperazine);

(3) Cathinone;

(4) Fenethylline;

(5) Methcathinone;

(6) 4-methylaminorex (also known as 2-amino-4-methyl-5-phenyl-2-oxazoline);

(7) N-ethylamphetamine;

(8) Any material, compound, mixture or preparation which contains any quantity of N,N-dimethylamphetamine.

(Other names include:

N,N,-alpha-trimethyl-benzeneethanamine and N,N-alpha-trimethylphenethylamine);

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 19(MCL\JAB) (9) Synthetic cathinones.

(A) Unless listed in another schedule, any compound other than bupropion that is structurally derived from 2-Amino-1-phenyl-1-propanone by modification in any of the following ways:

(i) By substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;

(ii) By substitution at the 3-position with an alkyl substituent;

(iii) By substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.

(B) The compounds covered in this paragraph (9) include, but are not limited to, any material, compound, mixture or preparation which contains any quantity of a synthetic cathinone found in any of the following compounds, whether or not substituted to any extent, or any of these compounds which contain any synthetic cathinone, or salts, isomers, or salts of isomers, whenever the existence of such salts, isomers or salts of isomers is possible, unless specifically excepted or listed in another schedule:

(i) 4-methyl-N-ethylcathinone ("4-MEC");

(ii) 4-methyl-alpha-pyrrolidinopropiophenone ("4-MePPP");

H.

B.

No.

4 *HR31/R944* ~ OFFICIAL ~ 23/HR31/R944 PAGE 20(MCL\JAB) (iii) Alpha-pyrrolidinopentiophenone ("α-PVP");

(iv) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one ("butylone");

(v) 2-(methylamino)-1-phenylpentan-1-one ("pentedrone");

(vi) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one ("pentylone");

(vii) 4-fluoro-N-methylcathinone ("4-FMC");

(viii) 3-fluoro-N-methylcathinone ("3-FMC");

(ix) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one ("naphyrone");

(x) Alpha-pyrrolidinobutiophenone ("α-PBP");

and (xi) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one (N-ethylpentylone, ephylone).

4 *HR31/R944**HR31/R944SG* ~ OFFICIAL ~ 23/HR31/R94423/HR31/R944SG ST:

include in Schedule I PAGE 21(MCL\JAB)11(MCL\JAB) controlled substance list.